United States Postmenopausal Vaginal Atrophy Treatment Market by Manufacturers, States, Type and Application, Forecast to 2022

Global Info Research
124 Pages
Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.


Scope of the Report:
This report focuses on the Postmenopausal Vaginal Atrophy Treatment in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers
Pfizer
Allergan
Shionogi
Novo Nordisk
Teva Pharmaceutical
Bayer.

Market Segment by States, covering
California
Texas
New York
Florida
Illinois

Market Segment by Type, covers
Creams
Tablets
Patches
Rings

Market Segment by Applications, can be divided into
Topical Estrogen
Systemic Estrogen
Non-hormonal Therapy

There are 17 Chapters to deeply display the United States Postmenopausal Vaginal Atrophy Treatment market.

Chapter 1, to describe Postmenopausal Vaginal Atrophy Treatment Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Postmenopausal Vaginal Atrophy Treatment, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Postmenopausal Vaginal Atrophy Treatment, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Postmenopausal Vaginal Atrophy Treatment market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Postmenopausal Vaginal Atrophy Treatment Research Findings and Conclusion, Appendix, methodology and data source.

Table of Contents
1 Market Overview
1.1 Postmenopausal Vaginal Atrophy Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Creams
1.2.2 Tablets
1.2.3 Patches
1.2.4 Rings
1.3 Market Analysis by Applications
1.3.1 Topical Estrogen
1.3.2 Systemic Estrogen
1.3.3 Non-hormonal Therapy
1.4 Market Analysis by States
1.4.1 California Status and Prospect (2012-2022)
1.4.2 Texas Status and Prospect (2012-2022)
1.4.3 New York Status and Prospect (2012-2022)
1.4.4 Florida Status and Prospect (2012-2022)
1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Profile
2.1.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Pfizer News
2.2 Allergan
2.2.1 Profile
2.2.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Allergan News
2.3 Shionogi
2.3.1 Profile
2.3.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Shionogi News
2.4 Novo Nordisk
2.4.1 Profile
2.4.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Novo Nordisk News
2.5 Teva Pharmaceutical
2.5.1 Profile
2.5.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Teva Pharmaceutical News
2.6 Bayer.
2.6.1 Profile
2.6.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Bayer. News
3 United States Postmenopausal Vaginal Atrophy Treatment Market Competition, by Manufacturer
3.1 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Postmenopausal Vaginal Atrophy Treatment Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share
3.4.2 Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share
3.5 Market Competition Trend
4 United States Postmenopausal Vaginal Atrophy Treatment Market Analysis by States
4.1 United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by States
4.2 United States Postmenopausal Vaginal Atrophy Treatment Sales by States (2012-2017)
4.3 United States Postmenopausal Vaginal Atrophy Treatment Revenue (Value) by States (2012-2017)
5 United States Market Segmentation Postmenopausal Vaginal Atrophy Treatment by Type
5.1 United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017)
5.1.2 United States Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017)
5.2 Creams Sales Growth and Price
5.2.1 United States Creams Sales Growth (2012-2017)
5.2.2 United States Creams Price (2012-2017)
5.3 Tablets Sales Growth and Price
5.3.1 United States Tablets Sales Growth (2012-2017)
5.3.2 United States Tablets Price (2012-2017)
5.4 Patches Sales Growth and Price
5.4.1 United States Patches Sales Growth (2012-2017)
5.4.2 United States Patches Price (2012-2017)
5.5 Rings Sales Growth and Price
5.5.1 United States Rings Sales Growth (2012-2017)
5.5.2 United States Rings Price (2012-2017)
6 United States Market Segmentation Postmenopausal Vaginal Atrophy Treatment by Application
6.1 United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
6.2 Topical Estrogen Sales Growth (2012-2017)
6.3 Systemic Estrogen Sales Growth (2012-2017)
6.4 Non-hormonal Therapy Sales Growth (2012-2017)
7 California Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
7.1 California Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
7.2 California Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
7.3 California Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
8 New York Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
8.1 New York Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
8.3 New York Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
9 Texas Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
9.1 Texas Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
9.3 Texas Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
10 Florida Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
10.1 Florida Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
10.3 Florida Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
11 Illinois Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers
11.1 Illinois Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type
11.3 Illinois Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
12 Postmenopausal Vaginal Atrophy Treatment Market Forecast (2017-2022)
12.1 United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Growth Rate (2017-2022)
12.2 Postmenopausal Vaginal Atrophy Treatment Market Forecast by States (2017-2022)
12.3 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Type (2017-2022)
12.4 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Application (2017-2022)
13 Postmenopausal Vaginal Atrophy Treatment Manufacturing Cost Analysis
13.1 Postmenopausal Vaginal Atrophy Treatment Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Price Trend of Key Raw Materials
13.1.3 Key Suppliers of Raw Materials
13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.2.1 Raw Materials
13.2.2 Labor Cost
13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment
14 Industrial Chain, Sourcing Strategy and Downstream Buyers
14.1 Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Manufacturers in 2016
14.4 Downstream Buyers
15 Sales Channel, Distributors, Traders and Dealers
15.1 Sales Channel
15.1.1 Direct Marketing
15.1.2 Indirect Marketing
15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers
16 Research Findings and Conclusion
17 Appendix
17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source


List of Tables and Figures

Figure Postmenopausal Vaginal Atrophy Treatment Picture
Table Product Specifications of Postmenopausal Vaginal Atrophy Treatment
Figure United States Sales Market Share of Postmenopausal Vaginal Atrophy Treatment by Types in 2016
Table Types of Postmenopausal Vaginal Atrophy Treatment
Figure Creams Picture
Table Major Manufacturers of Creams
Figure Tablets Picture
Table Major Manufacturers of Tablets
Figure Patches Picture
Table Major Manufacturers of Patches
Figure Rings Picture
Table Major Manufacturers of Rings
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Applications in 2016
Table Applications of Postmenopausal Vaginal Atrophy Treatment
Figure Topical Estrogen Picture
Figure Systemic Estrogen Picture
Figure Non-hormonal Therapy Picture
Figure California Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Postmenopausal Vaginal Atrophy Treatment Type and Applications
Table Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Postmenopausal Vaginal Atrophy Treatment Type and Applications
Table Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shionogi Basic Information, Manufacturing Base and Competitors
Table Shionogi Postmenopausal Vaginal Atrophy Treatment Type and Applications
Table Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Type and Applications
Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Type and Applications
Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer. Basic Information, Manufacturing Base and Competitors
Table Bayer. Postmenopausal Vaginal Atrophy Treatment Type and Applications
Table Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Manufacturer (2016-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2016
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2017
Table United States Postmenopausal Vaginal Atrophy Treatment Revenue by Manufacturer (2016-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2015
Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2016
Table United States Postmenopausal Vaginal Atrophy Treatment Price by Manufacturers (2016-2017)
Figure Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2016
Figure Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2017
Figure Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2016
Figure Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2017
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales by States (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by States (2012-2017)
Figure United States 2012 Postmenopausal Vaginal Atrophy Treatment Sales Market Share by States
Figure United States 2016 Postmenopausal Vaginal Atrophy Treatment Sales Market Share by States
Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Revenue by States (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by States (2012-2017)
Table United States 2012 Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by States
Table United States 2016 Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by States
Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Share by Type (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Revenue Share by Type (2012-2017)
Figure United States Creams Sales Growth (2012-2017)
Figure United States Creams Price (2012-2017)
Figure United States Tablets Sales Growth (2012-2017)
Figure United States Tablets Price (2012-2017)
Figure United States Patches Sales Growth (2012-2017)
Figure United States Patches Price (2012-2017)
Figure United States Rings Sales Growth (2012-2017)
Figure United States Rings Price (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Share by Application (2012-2017)
Figure United States Topical Estrogen Sales Growth (2012-2017)
Figure United States Systemic Estrogen Sales Growth (2012-2017)
Figure United States Non-hormonal Therapy Sales Growth (2012-2017)
Figure California Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)
Figure California Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)
Table California Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Table California Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table California Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Table California Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure New York Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)
Figure New York Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)
Table New York Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Table New York Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table New York Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Table New York Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure Texas Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)
Figure Texas Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)
Table Texas Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Table Texas Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table Texas Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Table Texas Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure Florida Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)
Figure Florida Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)
Table Florida Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Table Florida Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table Florida Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Table Florida Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure Illinois Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017)
Figure Illinois Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017)
Table Illinois Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Table Illinois Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table Illinois Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Table Illinois Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Growth Rate (2017-2022)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by States (2017-2022)
Table United States Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by States (2017-2022)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Type (2017-2022)
Table United States Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by Type (2017-2022)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Application (2017-2022)
Table United States Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Postmenopausal Vaginal Atrophy Treatment
Figure Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment
Figure Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis
Table Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Manufacturers in 2016
Table Major Buyers of Postmenopausal Vaginal Atrophy Treatment
Table Distributors/Traders/ Dealers List

captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

Asia-Pacific Stem Cell Media Market by Manufacturers, Regions, Type and Application, Forecast to 2022

GIR 2018-01-22 Pharma & Healthcare

Stem cells have the unique ability to self-renew or to differentiate into various cell types in resp...Read More

EMEA (Europe, Middle East and Africa) Preclinical Tomography System Market 2017 Forecast to 2022

GIR 2018-01-22 Pharma & Healthcare

Preclinical Tomography System is used tomography technology to the visualization of living animals f...Read More

EMEA (Europe, Middle East and Africa) Phytases Market 2017 Forecast to 2022

GIR 2018-01-22 Pharma & Healthcare

This report studies the Phytases market, A phytase (myo-inositol hexakisphosphate phosphohydrolase) ...Read More

Report's License Type

$4480
$8960

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.